Comparison of Hospital-at-Home models: a systematic review of reviews.
Man Qing Leong, Cher Wee Lim, Yi Feng Lai
https://pubmed.ncbi.nlm.nih.gov/33514582Actively Recruiting
Age: 18Years +
All Genders
ID07274072
Hospital at Home Versus Inpatient Care: Costs and Effectiveness
Led by Hospital at Home AG · Updated on 2025-12-10
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
H
Hospital at Home AG
Lead Sponsor
K
Klinik Hirslanden, Zurich
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the Hospital at Home (HaH) concept, which provides hospital-level care to acutely ill patients in their own homes. This includes daily medical and nursing visits, infusions, physiotherapy, diagnostics, and cooperation with hospitals and home care services. The study aims to demonstrate that HaH care is effective, safe, cost-efficient, and associated with high patient satisfaction compared to regular inpatient hospital care. Two main pathways are studied: admission avoidance, where stable patients are admitted directly to HaH, and early supported discharge, where hospital patients are discharged earlier to complete treatment at home. The study compares two groups: about 100 participants receiving hospital-equivalent care at home and 100 receiving traditional inpatient hospital care. Treatments include daily visits by physicians and nurses, infusion therapies, physiotherapy, and diagnostic procedures like blood tests, urine tests, ultrasound, and electrocardiography. Care is provided in partnership with hospitals, office-based physicians, home care organizations, and therapy providers. Both groups are monitored for treatment duration, therapy type, complications, and other health services used. Participants will be assessed for costs, mortality, rehospitalization, complications, patient satisfaction, length of stay, referrals to nursing homes or rehabilitation, and follow-up care. Data will be collected over one year or until 200 participants are included. The study will also track emergency department visits and home care types. Participants will complete questionnaires and be monitored for safety and outcomes throughout the study period, which starts in September 2025 and ends in August 2026.
CONDITIONS
Brief Title
Hospital at Home Versus Inpatient Care: Costs and Effectiveness
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Inpatients in the hospital or patients receiving Hospital at Home care
- Age 18 years or older
- Admission due to typical Hospital at Home diagnoses, including mild to moderate infections, exacerbated chronic obstructive pulmonary disease, heart failure, wounds, bleeding or anemia, dehydration, deterioration in multimorbid patients, infection-related complications in cancer, psychiatric problems including delirium, metabolic or autoimmune diseases, orthopedic issues, pain exacerbations, or palliative care up to terminal situations
- Patients without severe cognitive impairment who can provide informed consent and complete questionnaires
- Sufficient proficiency in written and spoken German or English
You will not qualify if you...
- Admission to hospital for reasons other than typical Hospital at Home diagnoses
- Refusal to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 1 year or until the total of 200 participants are included
Participants are observed during their treatment either at home with daily visits by physicians and nurses or as regular inpatients in the hospital, with assessments of clinical outcomes, complications, and patient satisfaction.
Daily visits for Hospital at Home group; regular hospital visits for inpatient group
Long-term Monitoring
Duration - Up to 1 year following treatment
Participants are followed after treatment to assess rehospitalization, referrals to nursing homes or rehabilitation clinics, emergency department visits, and ongoing patient outcomes.
Follow-up visits as needed with general practitioners or specialists
Trial Site Locations
Total: 1 location
1
Hospital at Home AG
Zollikon, Canton of Zurich, Switzerland, 8702
Actively Recruiting
Loading map...
Research Team
K
Kilian Braendle, Dr. med.
N
Natascha Furrer, Coordinator
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here